Zoetis Inc. Share Price

Equities

ZTS

US98978V1035

Pharmaceuticals

Market Closed - Nyse 01:30:02 11/05/2024 am IST 5-day change 1st Jan Change
169 USD +0.54% Intraday chart for Zoetis Inc. +1.18% -14.35%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 9.15B 764B Sales 2025 * 9.77B 816B Capitalization 77.13B 6,442B
Net income 2024 * 2.51B 210B Net income 2025 * 2.76B 231B EV / Sales 2024 * 8.9 x
Net Debt 2024 * 4.31B 360B Net Debt 2025 * 3.75B 313B EV / Sales 2025 * 8.28 x
P/E ratio 2024 *
30.9 x
P/E ratio 2025 *
28 x
Employees 14,100
Yield 2024 *
1.02%
Yield 2025 *
1.16%
Free-Float 90.82%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.54%
1 week+1.08%
Current month+6.15%
1 month+1.14%
3 months-14.33%
6 months-0.93%
Current year-14.35%
More quotes
1 week
161.00
Extreme 161
172.23
1 month
144.80
Extreme 144.8
172.23
Current year
144.80
Extreme 144.8
200.53
1 year
144.80
Extreme 144.8
201.92
3 years
124.15
Extreme 124.1483
249.27
5 years
90.14
Extreme 90.14
249.27
10 years
30.24
Extreme 30.24
249.27
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 01/12/01
Director of Finance/CFO 52 01/21/01
Chief Tech/Sci/R&D Officer - 01/11/01
Members of the board TitleAgeSince
Chairman 71 01/13/01
Director/Board Member 73 01/13/01
Director/Board Member 74 01/13/01
More insiders
Date Price Change Volume
10/24/10 169 +0.54% 2,010,749
09/24/09 168.1 +1.95% 2,145,422
08/24/08 164.9 -2.10% 4,673,075
07/24/07 168.4 +1.51% 3,337,509
06/24/06 166 -0.67% 3,081,343

Delayed Quote Nyse, May 11, 2024 at 01:30 am IST

More quotes
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%); - livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%); - other (1.1%). Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%). At the end of 2022, the group has 29 production sites worldwide. The United States accounts for 53.4% of net sales.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
169 USD
Average target price
211 USD
Spread / Average Target
+24.82%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW